Form 4: Ventyx Biosciences CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Martin Auster, CFO of Ventyx Biosciences, sold 1,405 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On April 2, 2024, Martin Auster, the Chief Financial Officer of Ventyx Biosciences, sold 1,405 shares of the company's common stock.
- The sale was executed at a weighted average price of $5.4035 per share.
- The shares were sold to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Auster directly owns 24,303 shares of Ventyx Biosciences.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The filing simply reports a sale of shares to cover tax obligations, which is a routine transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects. Sales to cover tax obligations are common and don't necessarily indicate a negative outlook.
Key Dates
| Date | Description |
|---|---|
| 04/02/2024 | Date of the transaction: Martin Auster sold 1,405 shares of Ventyx Biosciences common stock. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.